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Abstract 
In dynamic Positron Emission Tomography (PET) studies, compartmental models 
provide the richest information on the tracer kinetics of the tissue. Inverting such models at 
the voxel level is however quite challenging due to the low signal-to-noise ratio of the time 
activity curves. In this study, we propose the use of a Variational Bayesian (VB) approach to 
efficiently solve this issue and thus obtain robust quantitative parametric maps. 
 VB was adapted to the non-uniform noise distribution of PET data. Moreover, we 
propose a novel hierarchical scheme to define the model parameter priors directly from the 
images in case such information are not available from the literature, as often happens with 
new PET tracers. 
VB was initially tested on synthetic data generated using compartmental models of 
increasing complexity, providing accurate (%bias<2%±2%, root mean square error<15%±5%) 
parameter estimates. When applied to real data on a paradigmatic set of PET tracers (L-[1-
11C]leucine, [11C]WAY100635 and [18F]FDG), VB was able to generate reliable parametric 
maps even in presence of high noise in the data (%unreliable estimates<11%±5%). 
 
Highlights  
 Variational Bayesian (VB) approach is applied for the first time to PET data.  
 VB was adapted to the specific non-uniform noise distribution of PET data.  
 Various PET tracers described by different compartmental models were tested.  
 VB provided robust and accurate model estimates with low percentage of unreliable 
estimates. 
Keywords 
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1. Introduction 
Quantitative brain imaging with dynamic Positron Emission Tomography (PET) based 
on compartmental models can be performed at both region of interest (ROI) or voxel level. 
The analysis at the ROI level offers the advantage of a higher signal-to-noise ratio (SNR) 
allowing a more accurate and precise numerical identification of the model parameters. On 
the contrary, ROI analysis is prone to the intrinsic loss of the original spatial resolution and to 
the tacit assumption that the between-voxel variability of the time activity curves (TACs), 
averaged within the ROI, can be ignored or is not significant for the results. Voxel-wise 
quantification based on the full kinetic modelling overcomes these limitations but, in turn, it is 
hampered by the low SNR of the TACs derived from the single voxel. Nonlinear least squares 
estimators, which are considered the gold standard for ROI-based quantification, are too 
sensitive to the noise in the data at the voxel level and therefore parameter estimates are 
characterized by either high percentage of non-physiological estimates, lack of convergence 
or low precision (i.e. coefficient of variation of estimated parameters greater than 100% 
(DiStefano, 2015), page 546). Thus, the development of reliable and general-purpose 
parametric imaging methods remains a challenge for dynamic quantitative PET imaging. 
Nevertheless, during the last decade, several approaches have been proposed. Among them, 
the basis function method (Gunn et al., 1997; Koeppe et al., 1985; Rizzo et al., 2013a; 
Tomasi et al., 2009) is by far the most used for parametric imaging based on compartmental 
modelling, but its applicability is restricted to simple compartmental model structures. Other 
classical, albeit simplified, solutions for parametric imaging in PET are represented by 
graphical approaches (Logan et al., 1990; Patlak et al., 1983) and Spectral Analysis methods 
(Cunningham and Jones, 1993; Turkheimer et al., 2003; Veronese et al., 2012) but these 
approaches do not fully solve the underlying compartmental model (e.g. Spectral Analysis) 
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and they often do not return any information on the micro-parameters (individual 
compartmental rate constants of the model), as is the case for graphical methods. The 
identification of such micro-parameters is useful to fully characterize the physiology of the 
system, since there can be changes in pathological states which are not only linked to macro-
parameters of interest (Kotasidis et al., 2014): for example, a recent study found that skeletal 
muscle insulin resistance in type-2 diabetes involves a severe impairment of glucose 
transport and additional impairment in the efficiency of glucose phosphorylation (Goodpaster 
et al., 2014).  In addition, the use of  micro-parameters estimation at the voxel level has been 
shown to permit the identification of a pattern of cholinergic dysfunction in Alzheimer Disease 
(Marcone et al., 2012). Moreover, in the oncology field, fully quantitative parameters based on 
kinetic modelling could complement or even supersede semi-quantitative analysis in the 
clinical practice (Kotasidis et al., 2014).  
A valid alternative for parametric mapping is represented by Bayesian methods, which 
incorporate prior information on the tissue kinetics and have already been adopted in the PET 
community (Alpert and Yuan, 2009; Peng et al., 2008; Rizzo et al., 2012; Zanderigo et al., 
2010; Zhou et al., 2013). Prior information could also be included in hybrid approaches that 
combine reconstruction and kinetic modelling (Kamasak et al., 2005). Moreover, it is possible 
to incorporate structural and anatomical information obtained from magnetic resonance 
imaging (Loeb et al., 2015; Tang et al., 2010). 
However, despite providing robust estimates also at the voxel level, Bayesian methods 
proposed so far often do not have the required flexibility to be generalized to at least all the 
most common compartmental models, and when they do, their applicability to the clinical 
practice is undermined by the high computational time required for analysing a whole brain 
dynamic PET scan (up to several hours). For example, the Bayesian methods proposed by 
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Alpert and Yuan (2009) and Zanderigo et al. (2010) are based on nonlinear estimators and 
require high computational time. Furthermore, in (Alpert and Yuan, 2009), the prior 
information are obtained by analyzing a prior cohort of parametric images and there is 
therefore the necessity of having an additional sufficiently large data set to derive reliable a 
priori information. In Zhou et al. (2013), the quantification problem is tackled in a full Bayesian 
framework, solving the model with a Markov chain Monte Carlo (MCMC) sampling approach. 
In Peng et al. (2008) and Rizzo et al. (2012) the compartmental model is solved at the voxel 
level by linearizing the model (with an over-complete exponential basis set in Peng et al. 
(2008)) and then solving it using a Sparse Bayesian Learning or Maximum A Posteriori 
approach, respectively.  
The critical point of any Bayesian approach is the computation of the posterior 
distribution derived by the Bayes’ rule. Unfortunately, the numerical integrations involved are 
often computationally intractable. Sampling approaches, for example MCMC, are generally 
employed to calculate a numerical approximation of the posterior distribution. However, while 
these approaches are asymptotically exact, they are still too computationally expensive to be 
used for nonlinear Bayesian inference at the voxel level. An alternative is the Variational 
Bayesian (VB) method (Chappell et al., 2009), which is a fully Bayesian approach that uses 
an analytical approximation to simplify the calculation of the posterior distribution; this 
approximation is numerically tractable for both linear and nonlinear systems, including linear, 
time-invariant compartmental models. Whilst VB has previously been applied in the PET field 
for reconstruction and segmentation (Rapisarda et al., 2014; Xia et al., 2011),  it has never 
been applied for kinetic modelling. 
In the current study, VB is adapted and applied for quantitative parametric mapping of 
PET data. In order to demonstrate that VB is suitable as general Bayesian framework for 
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quantitative dynamic PET data, we first customised the VB algorithm to the peculiarities of the 
noise distribution in PET kinetic data (Zanoni et al., 2015). Secondly, we assessed VB 
performance using synthetic data generated using compartmental models having varying 
complexity, and, finally proposing a novel data driven prior generation, we applied VB to real 
data on a paradigmatic set of tracers representative of the variety of models used for PET 
quantification.  
 
2. Material and methods 
2.1. Theoretical framework of Variational Bayes 
In a Bayesian parameters estimation approach, a priori information is used to aid the 
numerical identification of the vector of the parameters   of a chosen model  from a set of 
measured data  . Bayes’ theorem links the calculation of the posterior distribution of the 
parameters given the data and the model ( (     )) to the a priori distributions of the 
parameters to be estimated ( (   )). This is obtained through the likelihood ( (     )), the 
probability density function that describes the data given the parameters and the model. 
Bayes’ rule can be written in a simpler form neglecting the dependence on the chosen model 
  as: 
  (   )  
 (   ) ( )
 ( )
 (1)  
In real applications, the numerical integrations needed for the direct computation of the 
posterior are usually intractable. Variational Bayesian approaches analytically approximate 
the actual posterior with a simpler form  ( ) (Attias, 2000), with the computational burden 
shifted to maximizing the agreement between true and approximate posterior. The distance 
between the approximation  ( ) and the true posterior distribution of the parameters  (   ) 
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can be measured via the Kullback–Leibler divergence     ( )   (   )  which, however, 
cannot be computed without knowledge of the true posterior. Nonetheless,    is equal to 
(Beal, 2003): 
     ( )   (   )      ( )    (2)  
where   is the Free Energy which is defined as: 
   ∫ ( )    
 (   ) ( )
 ( )
    (3)  
and since     ( ) does not depend on   and the Kullback–Leibler divergence is 
always non-negative, this latter can be minimized by maximizing  . 
To make the integrals tractable VB specifies a mean field approximation for  ( ). This 
consists in collecting the vector of parameters   into separate groups. In this work, one group 
included all the model parameters ( ) while the other only the parameter controlling for noise 
precision ( ). Each group is described by its own approximate posterior distribution (  (   ) 
and   (   ) ), which are assumed independent between them (i.e.  ( )    (   )  
  (   )). Furthermore, the use of prior conjugated with the likelihood, i.e. with the same 
parametric form of the posterior, simplifies the computation of the factorized posteriors, as the 
VB update becomes a process of updating the posterior hyper-parameters. The interested 
reader is referred to the original publications for a detailed derivation of the method (Attias, 
2000; Chappell et al., 2009). 
The method section is organized as follows: first, we will present the modifications 
required to apply VB to PET data, with a particular focus on the extension of the error model 
to non-uniform noise and the novel data-driven derivation of the priors. Then, we will present 
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several scenarios of simulated and clinical PET data that represent an extended set of case 
studies for the application of VB.  
 
2.2. Adapting the noise model to PET applications 
The model for the       vector of PET measurements  ( ) (representing the tracer 
concentration over time for a given voxel) is: 
  ( )   (   )   ( ) (4)  
where  (   ) is the compartmental model with the parameter vector   (which represents all 
the individual rate constants of the compartmental model) and  ( ) is additive Gaussian 
noise. For the sake of clarity, the dependency from the time   has been omitted in the 
following passages. 
In its original version, the VB approach assumed a constant level of noise for all the 
measurements, with zero mean and variance equal to    , i.e.    (      ). The non-
uniform sampling grid used in PET applications implies that, during each measured sample, 
the scintillation crystals are open to record the coincident pairs of photons emitted by the 
tracer for different time durations. The length of the time frames is chosen in order to detect a 
sufficient numbers of decay events to reconstruct the image. Hence, the level of noise will be 
different at each time point. This can be incorporated in the VB framework by introducing a 
non-identity covariance matrix    in the noise model: 
    (       )  (5)  
which is a diagonal matrix whose elements are calculated as the ratio between the measured 
tracer concentration   and the duration of the time frame   , i.e. for the i-th time point 
  (     )   (  )    ⁄ , as standard practice in dynamic PET studies (Bertoldo et al., 1998; 
Mazoyer et al., 1986). Nevertheless, in the first frames, this formula tends to underestimate 
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the noise relative variance since the tracer has not yet reached the voxel and therefore the 
term  (  ) is very small. This will be reflected in an exaggerated influence of the 
correspondent samples in the fitting procedure, providing an artificial overfitting. Therefore, in 
order to restrict their contribution on the likelihood (Zhou et al., 2013), we truncated the first 
time points’ precisions (assuring a maximum possible ratio of 10 between all precisions). The 
full modified equations for the VB update and the Free Energy formulation are reported in 
Appendix A. 
 
2.3. Data-driven prior definition 
The prior distributions chosen in this work are a multivariate normal distribution (MVN) 
for the vector of model parameters   and a Gamma distribution for the noise parameter  :  
  ( )    (       
  )  (6)  
  ( )   (       ) (7)  
 
and the factorized posteriors are chosen conjugate with the priors: 
   (   )    (     
  )  (8)  
   (   )   (     ) (9)  
where   and     are the mean vector and the covariance matrix of the MVN (with    and 
  
   as corresponding prior mean and covariance) and   and   are the shape and scale 
parameter of the Gamma distribution that parametrizes the noise variance (with    and    as 
corresponding prior values). 
The prior distribution of the parameters of the model can be set to literature values. 
However, it can be difficult to retrieve this kind of information, especially when the model is 
complex, or the tracer relatively new, or even when the quantification is performed on 
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patients, i.e. representing pathological conditions that can hamper the range of normality of 
the parameters. Nevertheless, it is possible to retrieve robust and reliable information directly 
from the data which can be used in place of strict prior information. Here we propose an 
approach similar to Empirical Bayesian methods (Casella, 1985), in which a weak prior 
distribution is estimated for the parameters using the data itself. In this scheme, the prior 
distribution is defined at the voxel level following a hierarchical scheme, where the estimates 
obtained from model-fitting at the region level with weighted nonlinear least squares are 
passed to the voxel layer as a priori information (WNLLS) (Rizzo et al., 2013a). WNLLS is 
considered the gold standard at the ROI level, and hence it is plausible that the prior retrieved 
is valuable.  
Figure 1 reports the workflow of the prior definition in a hierarchical fashion. Regional 
TACs can be obtained either by anatomical segmentation or by functional clustering. The 
compartmental model is solved for each ROI TAC by using WNLLS and the regional 
estimates are used as the MVN prior mean (  ) of the model parameters for all the voxels 
composing the selected region. In this way, different regions employ a tailored prior, but 
variations in the parameters value at the voxel level are still permitted in the inference 
procedure.   
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Figure 1. Workflow for the definition of the a priori distribution exploiting the 
hierarchical approach. The PET acquisition is sub-divided in regions of interest (ROIs) 
based on an anatomical atlas segmentation or functional clustering. A WNLLS estimator is 
used on the average TAC of each ROI to retrieve the mean of each parameter’s prior 
distribution (  ). For three representative ROIs the mean TAC (blue circles) and the fit 
obtained with the WNLLS estimator (black solid line) are reported. The prior distributions are 
defined from the WNLLS estimates and then hierarchically translated to each voxel of each 
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ROI. The precisions of priors are obtained using the formula     
 
(   ) 
 (Eq. 10) where   is 
chosen by simulations (see Data-driven prior definition section). 
 
As regard the precision of the model prior (  ), this must be set based on the level of 
variability in the estimates: a low variance will anchor the posterior mean to that of the prior 
distribution and a high level of variance will allow the parameters to be freely estimated from 
the (noisy) voxel level data. In the extreme case of an uninformative prior this would reduce to 
the WNLLS solution. Since it is very difficult to retrieve robust a priori information on the co-
variances, the off-diagonal elements of   were set to zero. This limitation can introduce a 
modest structure in the relation between parameters, considering them in principle 
independents. This is however not a restriction, since the estimator can infer the co-variances 
in the estimation process when supported from the data. 
We set the diagonal elements of    based on the region-wise WNLLS estimates 
(which correspond to the prior mean   ), multiplied by  , which gives a measure of the 
expected variability across the brain as:  
   
   
 {
 
 
(   
 )
    
          
 (10)  
Under the assumption that    coincides with the mean of the distribution of 
parameters inside the ROI,   corresponds to its coefficient of variation across voxels. This 
cannot be derived directly from the average TAC obtained at the ROI level and its value must 
be chosen in advance. This is done in a simulated environment by varying   on a suitable grid 
of values (from 5% to 200%), i.e. by varying the prior variance. The optimal   was defined in a 
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simulated scenario, with a sensitivity analysis (see section Simulation 2), and then applied to 
real cases.  
 
2.4. Application to simulated data 
Simulation studies were performed to:  
1) Assess the performance of VB compared to WNLLS in a paradigmatic sets of 
compartmental models: the two-tissue four-rate constants compartmental model (2TCM) 
simulated with fast (Rizzo et al., 2013a) and slow (Rizzo et al., 2013b) kinetics, and three-
tissue five-rate constants compartmental model (Bertoldo’s 5K model) (Bertoldo et al., 2001). 
2) Derive a measure of the variability   and evaluate the impact of a prior 
generated from the data at the ROI level on the VB estimates at the voxel level (sensitivity 
study). 
 
2.5. Simulation study 1: performance of VB and WNLLS 
The simulation was set up to generate synthetic TACs characterized by a signal-to-noise ratio 
comparable to voxel-level activities. We focused our analysis on the 2TCM model (the most 
common model in neuroreceptor studies) and 5K model (the compartmental model for 
[18F]FDG in skeletal muscle, a model more complex than the usual 2TCM). The model 
structure, equations and parameters of interest are reported in Figure 2A and 2C. 
Details on the tracers and ROIs used to simulate the synthetic data are reported in 
Table 1. The main steps of the simulation are showed in a pseudo-code fashion and details 
required  for its implementation are reported in the following. 
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Table 1.Tracers used to simulate the synthetic dataset. For each tracer the kinetics 
characteristic, the regions of interest considered and the reference to the original publication 
of the data are reported. 
 
Tracer Kinetics characteristics Regions of interest Reference 
[
11
C](R)-rolipram Slow 2TCM kinetics 
frontal cortex, thalamus 
and putamen 
(Rizzo et al., 2013b) 
[
11
C]WAY100635 Fast 2TCM kinetics 
cerebellum, frontal and 
temporal cortex 
(Rizzo et al., 2013a) 
[
18
F]FDG Irreversible 5K kinetics 
soleus and tibialis 
anterior 
(Bertoldo et al., 2001) 
 
Pseudo-Code of Simulation 1: performance of VB and WNLLS 
nT = number of tracers 
nR = number of ROIs 
nV = number of voxels 
nSV = number of synthetic voxels 
nMC = number of Monte Carlo realizations 
 
for  each tracer (t) 
 for each ROIs (r) 
  for each voxel (v) 
    ̂(v,r,t) = WNLLS_estimation(voxelTAC(v,r,t));  
  end 
 end 
  ̂
  
 = reliable and physiological estimates 
 
 % definition of true values 
           = MVN(mean( ̂  ), COV( ̂  )); 
 
 % prior definition 
     mean(         ); 
     (     (         ))
  
  
 
 for each synthetic voxel (sv) 
                =      (time,         (  )); 
   
  for each Monte Carlo realization (mcr) 
            =              (    ) + noise(:,mcr); 
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    ̂
     
(sv,mcr,t) = WNLLS_estimation(        ); 
    ̂
  
(sv,mcr,t) = VB_estimation(        ,  ,   ); 
  end % Monte Carlo realization 
 end % synthetic voxel 
end % tracer kinetics 
 
The VB estimation step can be summarized as: 
MaxIter = 100 
MaxTrials = 10 
Tolerance = 10
-6 
 
for i from 1 to MaxIter 
 Update noise, model parameters ( ̂  ) (Eq. A1-4) and FreeEnergy (Fnew) (Eq. 5) 
 if Fnew = Fold  tolerance 
  Return 
 else if Fnew > Fold 
  Update noise, model parameters (Eq. A1-4) and FreeEnergy (Eq. 5) 
  Trials = 0; 
 else if (Fnew < Fold) & (trials < Maxtrials) 
  Save current solution ( ̂  ) 
  Update noise, model parameters (Eq. A1-4) and FreeEnergy (Eq. 5) 
  Increment Trials 
 else 
  Discard further updates and provide saved solution 
  Return 
 end %termination criteria 
end %VB iteration  
 
For each tracer, the reliable voxel-wise estimates in a subset of the regions of interest 
(ROI) (reported in Tab.1) were selected from a representative subject. The ROIs were 
selected to represent the major peculiarities of the tracer kinetics. Each voxel was estimated 
using a WNLLS estimator. Then, the micro-parameter estimates, from every voxel of all the 
ROIs, were used to calculate the sample mean and covariance with the aim to define a MVN 
distribution representative of each tracer kinetics. Then, the unreliable and not physiological 
estimates were excluded, according to two criteria: 1) at least one micro-parameter should 
show a coefficient of variation greater than 100%, 2) the estimator did not reach convergence 
(maximum number of iterations reached). The coefficient of variation represents the precision 
of the parameter estimates and is calculated as the ratio between the estimated standard 
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deviation (derived by the inverse of the Fisher-information matrix when using WNLLS and 
from the posterior distribution in the VB case) and the expected value of the parameter. If the 
CVs are too high (e.g. CV>100%), the model is not a posteriori or numerically identifiable and 
should be rejected (Cobelli et al., 2002; DiStefano, 2015). 
To create a set of synthetic voxels comparable to an in-vivo dataset and in order to test 
both the VB and WNLLS performances, 1000 sets of micro-parameters were drawn from 
each MVN (i.e. we obtained 1000 sets of 5 parameters for both slow and fast 2TCM kinetics 
(  ,   ,   ,   ,   ) and 1000 sets of 6 parameters for 5K model (  ,   ,   ,   ,   ,   )). We 
also derived the macro-parameters of interest for the two models (   [ml/cm
3] volume of 
distribution for the 2TCM and    [ml/cm
3/min] irreversible uptake of the tracer in the tissues for 
5K model).  
From each set of parameter an impulsive response function was generated accordingly 
to equations reported in Figure 2A and Figure 2C. Then, a noise-free TAC for each set of 
micro-parameter, that represents a synthetic voxel, was generated by convolving the impulse 
response function with a metabolite-corrected arterial input function measured in previous 
studies.  
Each noise-free synthetic voxel TAC was used in a Monte Carlo simulation with 1000 
independent noise realizations. The noise variance was defined as in Eq. 5, where the 
proportionality constant     was fixed from the real data of the original studies (estimated a 
posteriori as in (Bertoldo et al., 1998)). 
 
In summary, 3 million TACs (1000 Monte Carlo realizations x 1000 synthetic voxels x 3 
tracer’s kinetics) were simulated and they were quantified with both WNLLS and VB. The 
priors for the VB estimator were independently generated for each tracer kinetics defining   
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as the mean of the MVN distribution used to generate the synthetic voxels and    as the 
variability (as 3 SD) across the  synthetic voxel set. These prior means were also used as 
initial values for WNLLS. 
The weights used in WNLLS were set as the inverse of the variance of the PET 
measurement error whose definition was the same as for VB. The unknown scale factor     
is intrinsically considered in the VB algorithm as  (   )⁄  from the gamma distributed 
factorized posterior, while it was estimated a 
posteriori as in (Bertoldo et al., 1998) for 
WNLLS. 
 
Figure 2. Summary of compartmental 
models and main outcomes The two-tissue 
four-rate constant compartmental model 
(2TCM, A), the two-tissue three-rate constants 
(3K model, B) and the three-tissue five-rate 
constants (5K model, C) are presented, along 
with the corresponding model equations and the 
main parameters of interest (  , volume of 
distribution, [ml/cm3] and   , net uptake rate 
constant, [ml/cm3/min]). Legend:    
[ml/cm3/min],    [1/min],    [1/min],    [1/min], 
   [1/min],   , arterial plasma;    , non 
displaceable binding;   , specific binding;   , 
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blood 11CO2;   , free L-[1-
11C]leucine;  , L-[1-11C]leucine incorporated into tissue protein;   , 
brain–blood equilibrium 11CO2 distribution volume;   , intracellular concentration;   , 
extracellular concentration;   , metabolized [
18F]FDG-6-phosphate intracellular 
concentration. 
 
 
 
 
2.6. Simulation study 2: prior sensitivity  
The second simulation aimed to evaluate the sensitivity of VB to both prior mean and 
precision. The simulation can be employed as a method to determine the optimal value of  , 
which represents a measure of variability of the parameters across the whole brain. As for 
simulation 1, the main steps of simulation 2 are reported for the sake of clarity in a pseudo-
code fashion, whereas the details on the implementation are reported in the following. 
 
Pseudo-Code of Simulation 2: sensitivity to the prior 
 
for each tracer (t) 
 clusters = kmeans(data(t)); 
 for each cluster with #voxels > 1000 (c) 
  for each voxel (v) 
    ̂(v,c,t) = WNLLS_estimation(voxelTAC(v,c,t));  
  end 
   
   ̂
  
 = reliable and physiological estimates 
  
  % definition of true values 
            = MVN(mean( ̂  ), COV( ̂  )); 
  % prior mean definition as real case 
      WNLLS_estimation(cluster(c).centroid); 
   
  for each synthetic voxel (sv) 
                 =      (time,         (  )); 
            =              (    ) + noise(  ); 
20 
 
   for         from 5% to 200% with step of  5%  
    % prior precision definition 
        (   )
    
     ̂
  
(sv,c,t) = VB_estimation(        ,  ,   ); 
   end %    
  end % synthetic voxel 
 end % cluster 
end % tracer kinetics 
 
For each tracer, the same representative subject used in simulation 1, selected from 
the available datasets, was analyzed with a K-means algorithm, with a fixed number of 20 
clusters, 1000 iterations and 10 replicates. The clusters with less than 1000 voxels were 
excluded from further analysis. For the remaining clusters each voxel was analyzed with the 
WNLLS estimator. The micro-parameters estimated were then filtered with the same criteria 
used in simulation 1, including only physiological solution and reliable estimates. The 
remaining voxel estimates were used to estimate mean and co-variance of a MVN 
distribution, that was then used to sample 1000 noise-free synthetic voxels TAC following the 
same procedure as in simulation 1. Each noise-free synthetic voxels TAC was then 
independently corrupted with additive noise. The variance of the noise was set following Eq. 
5. The prior mean (  ), to be used with VB, was defined from the mean TAC of each 
synthetic voxel set. The averaged TAC was analyzed with a WNLLS estimator and the 
estimated micro-parameters were assigned as the mean of the prior. This procedure was 
used to mimic a real-world scenario, where the averaged TAC obtained from the cluster or the 
ROI is used to infer the estimates at the voxel level. The estimation with VB estimator was 
carried out for each synthetic voxel and several values of  . To identify the optimal  , the prior 
precision was set to the square inverse of    , according to Eq. 10, with   varying from 5% 
up to 200% with steps of 5%. The criteria to choose the optimal   was the absolute mean 
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percentage error between micro-parameters and synthetic voxels. A more detailed description 
of the evaluation is reported in the next section. 
 
2.7. Assessment of simulated data results 
For each simulated scenario, both VB and WNLLS estimates were corrected for 
unreliable estimates following the same criteria used in both simulations.  
The comparison was then conducted at the intersection of voxels where both methods 
gave reliable estimates. The model kinetic rate constants and the macro-parameters of 
interest were compared with the correspondent true values. Percentage mean bias (     ) 
and root mean square error (     ) were used as indexes of performance: 
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where   indicates the number of simulations ( =1,000),  ̅ indicates the true parameter 
and    indicates the i-th estimated parameter.  
For the selection of the optimal  , separately for each tracer, cluster and synthetic 
voxel micro-parameters estimates, the absolute percentage error was computed. This was 
averaged across voxels and micro-parameters, obtaining for each cluster an index of 
performance, function of  :  
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We selected the optimal   as the mean   between clusters that minimized the mean 
absolute percentage error. This parameter can quantify in a single performance index the 
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sensitivity to the prior mean and precision, since for each cluster the analysis was repeated 
independently re-generating the prior mean and exploring a wide range of possible levels of 
precision. We calculated for a single optimal  , considered as the mean of the optimal   
between tracers, the percentage mean bias (Eq. 11) on the micro-parameters for each tracer 
and for each cluster. 
 
2.8. Application to in vivo positron emission tomography data 
We applied VB to clinical PET data, considering both reversible and irreversible 
tracers, described by compartmental models of different complexity: 1) L[1-11C]leucine, 
marker for regional rates of cerebral protein synthesis (Bishu et al., 2008); 2) 
[11C]WAY100635, targeting serotonin 5-HT1A receptor (Bose et al., 2011); 3) [
18F]FDG in 
skeletal muscle, marker for the glucose metabolism (Bertoldo et al., 2006). For each PET 
dataset we considered three subjects as representative test cases.  
The choice of these tracers was based on the compartmental models used in the 
literature to describe their kinetics. The model structure, equations and parameters of interest 
are reported in Figure 2. In particular, we considered:  
- a two-tissue three-rate constant (3K) model (Fig. 2B), which is here used to 
describe the irreversible kinetics of L[1-11C]leucine. To note that it has the same complexity of 
the Sokoloff model to describe [18F]FDG kinetics in brain (Sokoloff et al., 1977); 
- the classic 2TCM model (Fig. 2A), used to describe the kinetics of 
[11C]WAY100635; 
- the 5K model (Fig. 2C), for the [18F]FDG in skeletal muscle.  
As result of this selection we therefore considered:  
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L[1-11C]leucine: Three male healthy subjects of a previously published study (age 20 to 
24) underwent a 90-min dynamic PET scan in a HRRT (CPS Innovations, Knoxville, TN, 
USA) scanner after a 2-min intravenous infusion of 20 to 30 mCi of L[1-11C]leucine. The 
criteria for subject inclusion and the procedure for the PET studies are described in detail in 
(Bishu et al., 2008). Twenty-one regions of interest were derived as described in Veronese et 
al. (2010).The PET acquisition facility: NIH PET centre, Bethesda, Maryland (USA). 
[11C]WAY100635: Three male healthy subjects of a previously published study (35.7 ± 
10.5 years old) underwent a 95-min dynamic PET study in an ECAT EXACT3D 
(Siemens/CTI, Knoxville, TN, USA) scanner after a bolus injection of 301± 12 MBq of 
[11C]WAY100635. Full details on PET procedures, arterial data extraction and processing are 
reported in Bose et al. (2011). Forty-six ROIs were derived from the Hammersmith Brain Atlas 
(Hammers et al., 2003) as described in Bose et al. (2011). PET acquisition facility: Imanet 
PET centre, London (UK). 
[18F]FDG: Three male healthy subjects of a previous study (36 ± 5 years old, body 
mass index = 22.6 ± 0.8 kg/m2) were considered (Bertoldo et al., 2006). The subjects were 
studied in the fasting state and underwent a 90-min dynamic PET scan in a ECAT HR+ 
(Siemens/CTI, Knoxville, TN, USA) after injection of 6 mCi of [18F]FDG. Details on subject 
inclusions, PET procedures and processing are reported in Bertoldo et al. (2006). The ROIs 
included in the analysis were the anterior tibialis and the soleus muscles, as described in 
Bertoldo et al. (2006). PET acquisition facility: Pittsburgh PET centre, Pittsburgh (PA, USA). 
We want to highlight that all the datasets were acquired independently and therefore 
experimental settings changed across studies. For example, the brain segmentation was 
inconsistent between datasets, since the regions definition was selected to best match the 
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particular tracer tissue distribution. These characteristics represented the best conditions to 
test the flexibility and robustness of VB. 
For all the datasets, voxel-wise estimates of    (for 2TCM) and    (for 3K and 5K 
models) were obtained with WNLLS and VB applied to the corresponding compartmental 
models as in the simulation studies, i.e. including the extended error model.  
The priors for VB estimator were generated using the hierarchical approach described 
above: WNLLS was applied to the ROI TACs and then    was set equal to the region-wise 
WNLLS estimates and    was defined as in Eq. 10, with   determined from the simulation 
results.  
VB and WNLLS voxel-wise estimates were compared at the intersection of voxels 
where both methods gave reliable estimates, after correction for unreliable estimates. WNLLS 
estimates were considered as reference values for the comparison despite its sensitivity to 
initial estimates and non-convergence in a significant percentage of voxels. Nevertheless, 
when WNLLS converges, its results are characterized by the same properties as the 
estimator itself, i.e. non polarization, consistency, asymptotic normality, and efficiency (Cobelli 
and Carson, 2001). 
We compared unreliable estimates percentage, correlation (as Pearson’s correlation 
coefficient   ), slope and intercept of the regression analysis and the mean relative difference 
(MRD) between VB and WNLLS estimates as performance indexes. We considered both 
micro- and macro-parameters of interest. Computational time was measured for each voxel of 
each subjects of the three datasets available for both VB and WNLLS. Both algorithms were 
implemented with no parallelism using MATLAB Release 2015b, The MathWorks, Inc., 
Natick, Massachusetts, United States. The analysis was carried out on a quad core Intel Xeon 
E5450 Processor (3.00 GHz).  
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3. Results  
3.1. Simulation study 1: performance of VB and WNLLS 
Results of the first simulation showed comparable performance in term of bias in the 
parameter estimates between VB and WNLLS (Table 2). The macro-parameters of interest 
(   for 2TCM and    for 5K model) were estimated with negligible bias in the three considered 
cases, while micro-parameters exhibited slightly higher biases. The micro-parameter    in the 
2TCM simulation with slow kinetics showed the highest bias for both VB and WNLLS (-
10%±27% and -12%±23% respectively). It is interesting to note that for the most complex 5K 
all the parameters were estimated with a bias smaller than 10%. 
 
Table 2. Percentage bias of VB and WNLLS estimators in 3 different simulated cases (2TCM 
fast and slow kinetics and 5K kinetics). Bias is reported for each micro- and macro-parameter 
as mean (SD). The macro-parameters of interest are    [ml/cm
3] volume of distribution for the 
2TCM and    [ml/cm
3/min] irreversible uptake of the tracer in the tissues for 5K model 
  
   
[ml/cm3/min] 
    
[1/min] 
    
[1/min] 
    
[1/min] 
    
[1/min] 
    
[unitless] 
Macro-
parameter 
2
T
C
M
 f
a
s
t 
k
in
e
ti
c
s
 
WNLLS -1 (2) -1 (5) 3 (4) 3 (2) - - -5 (12) -1 (1) 
VB 1 (6) 4 (13) 6 (9) 4 (5) - - -3 (10) -2 (2) 
                
2
T
C
M
 s
lo
w
 
k
in
e
ti
c
s
 
WNLLS 1 (7) -1 (20) -9 (32) 3 (14) - - -12 (23) -1 (3) 
VB 0 (9) -2 (25) -4 (42) 1 (22) - - -10 (27) 0 (3) 
                
5
K
 k
in
e
ti
c
s
 
WNLLS -2 (5) -9 (19) -8 (15) -7 (19) -2 (12) 4 (11) 0 (1) 
VB 0 (8) 0 (20) 6 (15) 9 (23) 3 (17) -6 (19) 0 (2) 
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When considering the RMSE (Table 3), the difference between VB and WNLLS 
performance became evident: for both micro- and macro-parameters in all the three 
considered cases VB yielded lower mean RMSE with significantly lower variability. 
 
Table 3. Root mean square error (RMSE) of VB and WNLLS estimators in three different 
simulated cases (2TCM fast and slow kinetics and 5K kinetics). RMSE is reported for each 
micro- and macro-parameter as mean (SD). The macro-parameters of interest are    [ml/cm
3] 
volume of distribution for the 2TCM and    [ml/cm
3/min] irreversible uptake of the tracer in the 
tissues for 5K model. 
  
   
[ml/cm3/min] 
    
[1/min] 
    
[1/min] 
    
[1/min] 
    
[1/min] 
    
[unitless] 
Macro-
parameter 
2
T
C
M
 f
a
s
t 
k
in
e
ti
c
s
 
WNLLS 30 (8) 63 (16) 47 (13) 32 (9) - - 38 (16) 19 (8) 
VB 20 (4) 38 (9) 33 (8) 26 (5) - - 32 (11) 15 (5) 
                
2
T
C
M
 s
lo
w
 
k
in
e
ti
c
s
 
WNLLS 50 (122) 131 (407) 132 (178) 94 (170) - - 85 (164) 23 (19) 
VB 16 (3) 35 (10) 52 (17) 34 (7) - - 34 (7) 11 (3) 
                
5
K
 k
in
e
ti
c
s
 
WNLLS 45 (12) 95 (21) 61 (11) 95 (28) 63 (19) 84 (30) 10 (3) 
VB 19 (3) 38 (10) 35 (10) 57 (34) 38 (10) 48 (13) 7 (2) 
 
Also the percentage of outliers was significantly lower for VB than for WNLLS (3.4% 
vs. 8.5% in the 2TCM with fast kinetics; 8.9% vs. 39.8% in the 2TCM with slow kinetics and 
7.9% vs. 14.4% in the 5K kinetics).  
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To summarize, both VB and WNLLS showed low bias but VB was more accurate 
(lower RMSE) and had better convergence properties due to the regularization introduced by 
the priors. 
 
3.2. Simulation study 2: sensitivity analysis  
The sensitivity analysis of VB estimator was conducted in a simulated “real-world” 
scenario. The simulation can be employed as a method to evaluate the optimal precision level 
of the prior (dependent on  ) on several clusters composed by synthetic voxels. The prior 
mean was re-generated for each cluster from the averaged TAC obtained from the simulated 
synthetic noisy voxel TACs. The mean absolute percentage error across micro-parameters 
and synthetic voxels is reported, as a function of lambda in Figure 3. The analysis was 
conducted for each tracer kinetics and each cluster independently and showed a similar 
behaviour. The minimum of the curve was located in a very narrow window, spanning values 
of   from 0.4 up to 0.6. A boxplot representing the optimal   of all simulated clusters, for each 
tracer kinetics is reported in the bottom panel of Figure 3 and shows a homogeneous optimal 
  distribution. The Fast 2TCM simulated dataset provided an optimal   (across the simulated 
clusters) of 0.58±0.07, while the Slow 2TCM 0.5±0.05 and the optimal   for the 5K Irreversible 
kinetics simulated dataset was 0.48±0.07. Considering all datasets as a whole the optimal 
value was 0.5±0.07. 
28 
 
 
 
Figure 3. Sensitivity analysis.  The mean absolute 
percentage error is reported in separate graphs, showing 
respectively the mean (black solid line) and mean ± 
standard deviation (blue solid line) across clusters as a 
function of   for A) 2TCM for tracers with slow kinetics, B) 
2TCM for tracers with fast kinetics and C) 5K irreversible 
kinetics. Optimal   ranges across clusters are reported 
with dashed red lines. The bottom panel (D) reports the 
boxplot of optimal   for each tracer kinetics across the 
simulated clusters.   
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Therefore, based on this empirical approach, the optimal   suggested to be used in 
clinical settings with these tracers is 50%, which means that the standard deviation of the 
priors should be set to half the estimates obtained from the average TACs. 
To further address the performances of VB when used in real case settings, we report 
the percentage bias obtained when the proposed value of   is used. The bias on the micro-
parameters range is comprised in -4.6% and 1.6% for the simulated 2TCM slow kinetics 
dataset; while for the simulated 2TCM fast kinetics is between -9.5% and 1.7% and lastly the 
5K irreversible kinetics dataset has a bias range between -8.8% and 14%. 
 
Figure 4. Bias on micro-parameters.  The 
illustration provides a boxplot of the 
percentage bias on micro-parameters for the 
simulated tracer kinetics (A) 2TCM fast 
kinetics (B) 2TCM slow kinetics and (C) 5K 
irreversible kinetics. The value of       was 
used to provide an insight into the 
performance of VB in a real scenario when a 
regional TAC is used to infer the voxel level 
estimates with the proposed optimal   value. 
The values reported in the boxplot are the 
mean percentage bias calculated across the 
synthetics voxels of the simulated clusters. 
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3.3. Application to in vivo positron emission tomography data 
Based on the results of the second simulation, we used       as measure of 
variability to set the inverse of the prior variance for all the tracers considered.  
The VB results on clinical data confirmed what we previously observed in simulations: 
the main impact of the method was the percentage of outliers. This can be easily appreciated 
from the parametric maps of Figure 5, where it is clear that VB allows recovery of the 
physiological information in the majority of the voxels. In L-[1-11C]Leucine dataset, WNLLS 
yielded a considerable number of unreliable estimates, i.e. 34%±20%, while on average VB 
failed to converge to a reliable solution only on 1%±1% of the voxels (Figure 5A). Also for 
[11C]WAY100635 the number of unreliable estimates was significantly lower for VB than for 
WNLLS (8%±9% vs 60%±12% respectively) (Figure 5B). The most striking result was 
obtained with [18F]FDG dataset where WNLLS yielded a percentage of unreliable estimates of 
66%±12% while VB only 11%±5% (Figure 5C).  
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Figure 1. Parametric maps. The parametric maps of    (A, L-[1-
11C]Leucine and C, 
[18F]FDG) and    (B, [
11C]WAY100635) obtained with WNLLS and VB. For each dataset 
results refer to a transaxial and a sagittal slice for a representative subject. Parametric maps 
are presented in their raw form without any smoothing. 
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Figure 6. Scatter analysis of    and    
estimates. The average value of    (for L-[1-
11C]Leucine (21 ROIs) panel A, and [18F]FDG (3 
ROIs), panel C) and    (for [
11C]WAY100635 (46 
ROIs), panel B) obtained within each ROI 
estimated using WNLLS (x axis) and VB (y axis) 
for all subjects. Pearson’s value   , slope and 
intercept of the fitted regression line are reported. 
 
 
 
 
 
 
 
 
The results obtained with WNLLS and VB (where both method converged to reliable 
solution) were all highly correlated: as regards the L-[1-11C]Leucine dataset, the estimates of 
   obtained with WNLLS and VB showed high correlation and limited mean relative difference 
(R2=0.98; MRD=3%±6%; m=1.05; q=-0.0001) (Figure 6A).  
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Similar results were obtained for the    estimates of [
11C]WAY100635: these were 
highly correlated (R2=0.93) and showed low MRD (5%±12%) between VB and WNLLS 
(Figure 6B). The regression parameters were        and        .  
Also [18F]FDG    estimates showed excellent agreement between the two methods 
(R2=0.99; MRD=-2%±4%; m=0.97 q=0.0001) (Figure 6C).  
Kolmogorov–Smirnov test with a 5% significance level was used to check if weighted 
residuals produced by VB came from a standard normal distribution. All datasets considered, 
no evidence of deviation from the model error assumptions was found in the vast majority of 
voxels (96.3%). 
The average calculation time of VB varied from 0.02s to 0.2s per voxel, depending on 
the model complexity (0.02s per voxel for the 3K model of L-[1-11C]leucine, 0.025s per voxel 
for the 2TCM of [11C]WAY100635 and 0.2s per voxel for the 5K model of [18F]FDG skeletal 
muscle). VB was 27%±20% faster than WNLLS for [11C]WAY100635 and 13%±34% faster for 
[18F]FDG. As regard L-[1-11C]Leucine, computational time was comparable. The bottom line is 
that the computational time improvement was proportional to both model complexity and 
noise level. Furthermore, the total time required to complete a scan depended on the number 
of voxels in the image and the number of samples of the interpolated input function. In fact, 
the plasma input functions were metabolite-corrected when necessary (Tonietto et al., 2015b) 
and optimally fitted as in (Tonietto et al., 2015a). The number of samples used for the 
modelled input function varied across the datasets (from 400 to 800 samples per subject), 
impacting on the VB computational time. On average VB took 80 min to complete a 
[11C]WAY100635 brain scan (100’000 voxels), 3.5 hours for a L-[1-11C]leucine HRRT brain 
scan (650’000 voxels) and 8 hours for a [18F]FDG skeletal muscle scan (150’000 voxels).  
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4. Discussion 
In this work we presented a Variational Bayesian approach for the voxel-wise full 
kinetic quantification of PET data. The method uses an analytical mean field approximation of 
the posterior distribution, originally presented by (Chappell et al., 2009) and successfully 
applied to magnetic resonance imaging and ultrasound data (Rizzo et al., 2016). Here we 
applied it for the first time to a paradigmatic set of PET tracers considering both simulated and 
real data.  
 
4.1. Method applicability and performances 
We focused our study on brain imaging data, but we extended our analysis to whole 
body imaging in order to prove the general applicability of the method for PET quantitative 
parametric mapping.  
Indeed, Variational Bayesian approach as set up in this work can be used to solve any 
compartmental model at the voxel level, and therefore it has wide applicability. We 
demonstrated this by applying VB to three different models: 2TCM, 3K and 5K models. Since 
the majority of brain PET kinetic studies employ a 2TCM model for quantification of in vivo 
receptor binding, we considered 2TCM in first instance, by validating the use of VB in both 
synthetic and real PET data, characterized by different transport rate constants. Then, we 
evaluated VB performance when applied to a classical but less complex model, i.e. the 3K 
model, which is the model used in this work to describe L-[1-11C]Leucine. It is worth noting 
that the 3K model is the predominant compartmental model used to describe [18F]FDG in the 
brain. Last, we considered one of the most complex model used in PET, i.e. the 5K model 
exploited to quantify the [18F]FDG PET tracer kinetics in skeletal muscle. 
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In all cases, VB outperformed the conventional WNLLS by providing accurate and 
robust estimates, with a substantial lower percentage of outliers. VB accuracy was also 
compared in one of the data-set included ([11C]WAY100635), to a classic Markov Chain 
Monte Carlo (MCMC)  Bayesian estimator (see supplementary material for more details on 
this comparison). In Figure S2,    maps obtained with both VB and MCMC show a very 
strong correlation (Pearson R2=0.99). MCMC does not rely on the mean field approximation 
exploited by VB. Therefore the high agreement reached between VB and MCMC, confirmed 
also by previous results (Chappell et al., 2009), suggest that this approximation is indeed 
reasonable in this context. 
Since the compartmental model is solved at the voxel level, VB returns also the maps 
of microparameters   ,   ,   ,   ,    (and    in the case of [
18F]FDG in skeletal muscle). 
These provides more detailed information about the physiology of the system under study 
and, furthermore, they allows the calculation of other parameters of interest in addition to the 
standard    or   . For example, it is possible to derive the fraction of unlabeled leucine in the 
precursor pool for protein synthesis      (    )  
 (     )⁄  where   
  is the arterial 
plasma concentration of unlabeled leucine. In supplementary material, Figure S1 reports the 
     (L-[1-11C]leucine, panel A),  and    ([
18F]FDG, panel B). Compared to WNNLS, VB 
allows the recovery of the physiological information in almost the totality of the voxels. 
 
4.2. Extended noise model 
Differently from magnetic resonance imaging, where the noise variance is uniform 
across the time of the experiment, in PET the non-uniform sampling grid and the radioactive 
decay of the tracer entail that the level of noise will be different at each time point. Therefore, 
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we modified the original formulation of VB to adapt it to a non-uniform noise distribution. 
Analysis of the weighted residuals confirmed the correctness of the noise model. 
 
4.3. Prior definition 
Differently from the original work (Chappell et al., 2009), where the priors were set 
based on typical parameter values from the literature and expected physiological variation, we 
implemented a data-driven solution for the definition of the prior that are gathered directly 
from the data. Following the same approach previously published in (Rizzo et al., 2012), we 
implemented a hierarchical scheme, where the estimates obtained at the region level with a 
WNLLS estimator, considered the gold standard for PET quantification at high signal-to-noise 
ratio, were used to define the priors for the voxel level analysis. The region segmentation can 
be generated either by anatomical atlas segmentation or by functional segmentation using 
unsupervised clustering.  
Another important aspect of the method is the definition of the prior precision   . We 
defined    as the square inverse of     , i.e. the prior mean times  . It is worth noting that 
the co-variance matrix (  
  ) used is diagonal, hence that the prior distributions are 
independent. This, however, will not preclude the posterior probability from being dependent 
and hence, when supported from the data, the method could account for correlation between 
rate-constants. Moreover, when prior information on the dependencies between rate-
constants is available it would be possible to account for it in the covariance matrix.  
The value of   was set via simulations since it is not possible to infer it directly from the 
data. In the simulated scenarios we found an optimal value of  =0.5 (2TCM slow kinetics), 
 =0.58 (2TCM fast kinetics) and  =0.52 ([18F]FDG kinetics), that support the general use of a 
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value of  =0.5., which is the value that we suggest to be used also for the quantification of 
other PET tracers than those presented in the current study.  
When applied to the real data in this study, the prior variance defined with  =0.5 did 
not constrain the VB estimates to the prior mean value, but on the contrary allowed to detect 
heterogeneity across the regions of interest (Fig. 7). Also, the percentage differences 
between the VB estimates and prior mean values were not randomly distributed in the brain, 
but presented a spatial patterns in agreement with the physiology (e.g. positive (negative) 
differences in the grey (white) matter for L-[1-11C]leucine or [11C]WAY100635).  
We also calculated for each tracer an index of heterogeneity within each region as the 
ratio between the standard deviation and the mean of the VB estimated macro-parameters 
within the ROI. Heterogeneity levels varied between 15% and 30% in tissues for L-[1-
11C]leucine and [18F]FDG (supplementary tables S1 and S3), whereas was slightly higher for 
[11C]WAY100635 images, varying from 29% to 69%. However, the [11C]WAY100635 images 
were segmented with an anatomical atlas of 73 regions, comprising both WM and GM 
tissues, that can justify the higher heterogeneity levels. The mean value of heterogeneity in all 
regions was 45% (with a standard deviation of 10%). 
We also tested whether the prior variance was too restrictive, therefore artificially 
reducing the posterior estimates heterogeneity. We repeated the quantification analysis on 
the real data but doubling the value of   (from the optimal value of 0.5 found in simulation, to 
  =1). In this way, the resulting prior variance was 4-fold the one set originally. We saw a 
modest increase (maximum 4.6%) of heterogeneity within the ROIs (calculated as the ratio 
between standard deviation and mean of the VB macro-parameter estimates within the 
region) for the L-[1-11C]leucine data (Supplementary Figure S3-S4, Supplementary table S1). 
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Figure 7. Prior maps and tissue variability. First Column) Prior mean map obtained for    
(A, L-[1-11C]Leucine and C, [18F]FDG, obtained after k-means clustering) and    (B, 
[11C]WAY100635, obtained with Atlas Segmentation). Second Column) Percentage 
differences between the prior mean and the VB estimates (the same reported in Fig. 3) that 
represents the tissue physiological heterogeneity that VB was able to detect. For each 
dataset results refer to a transaxial and a sagittal slice for a representative subject. Maps are 
presented in their raw form without any smoothing. 
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Based on these results, we suggest  =0.5 to be used also for the quantification of 
other PET tracers than those presented in the current study. 
  
5. Conclusions 
Variational Bayesian approach is applied for the first time to PET data. It provides 
robust and accurate parameter estimates with low percentage of outliers. Computational time 
required for a whole brain analysis is compatible with clinical practice, even when complex 
compartmental models are employed. 
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Appendix A 
VB updates and Free Energy formulation for PET data  
The extension of the noise model affects the VB update equations which become: 
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where   represents the vector of the residuals between the data and the model prediction and 
  is the Jacobian of the model (        ( )    ⁄  , i.e. the first-order partial derivatives of the 
model  ( ) with respect to the parameters  ). 
 Last, also the Free Energy formulation should be adapted: 
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(A.5)  
where    is the number of model parameters,  ( ) is the Gamma function and  ( )  
 (    ( ))   ⁄  is the digamma function, i.e. the logarithmic derivative of the Gamma function. 
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